Stay updated on Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Results have been submitted for this study, replacing the previous 'No Results Posted' status.
    Difference
    0.0%
    Check dated 2026-03-26T11:28:11.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-19T04:59:08.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Site revision tag updated from v3.4.2 to v3.4.3. The change does not modify any study data or page content.
    Difference
    0.0%
    Check dated 2026-03-12T00:55:05.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new site revision (v3.4.2) was added and older v3.4.1 funding-status notices were removed. These updates are maintenance-related and do not alter study information or user interaction on the page.
    Difference
    0.3%
    Check dated 2026-02-11T11:55:25.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH Clinical Center operations, with guidance to check opm.gov for status updates. Updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:26:05.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Added a Show glossary toggle and updated QC metadata (Last Update Submitted that Met QC Criteria) with Revision: v3.4.0, while removing the prior lowercase label, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T06:00:36.000Z thumbnail image

Stay in the know with updates to Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.